Thrombosis and Haemostasis, Table of Contents Thromb Haemost 1983; 49(02): 144-146DOI: 10.1055/s-0038-1657341 International Committee Communications Schattauer GmbH Stuttgart Report of the Working Party on Acquired Inhibitors of Coagulation: Studies of the “Lupus” Anticoagulant Authors Author Affiliations D Green * The Atherosclerosis Program/Northwestern University, Rehabilitation Institute of Chicago, Illinois C Hougie ** The University of California, San Diego, LaJolla, California F J Kazmier *** The Mayo Clinic/Special Coagulation Lab, Rochester, Minnesota, U.S.A. K Lechner *+ The I. Medizinische Universitätsklinik, Vienna, Austria P M Mannucci + The Universita Degli Studi Di Milano, Milan, Italy C R Rizza ++ The Oxford Haemophilia Centre, Oxford, England Y Sultan +++ The Service d'Hematologie de I'Hdpital Cochin, Paris, France Recommend Article Abstract PDF Download(opens in new window) Buy Article(opens in new window)Keywords KeywordsLupus anticoagulant - Inhibitors of coagulation PDF (890 kb) References References 1 Schleider MA, Nachman RL, Jaffe EA, Coleman M. A clinical study of the lupus anticoagulant. Blood 1976; 48: 499-509 2 Denson KWE, Biggs R. Laboratory diagnosis, tests of clotting function and their standardization. Human Blood Coagulation, Hemostasis, and Thrombosis. Biggs R. (ed). p. 325. Blackwell Scientific Publications; Oxford: 1976 3 Kaspar CK. et al. A more uniform measurement of factor VIII inhibitors. Thrombos Diathes Haemorrh 1975; 34: 869-872 4 Kalish SB, Kurtides ES, Semerdjian RA, Vagher P. Bleeding in patients with activated partial thromboplastin time inhibitors. South Med J 1982; 75: 494-496 5 Shapiro SS, Thiagarajan P. Lupus anticoagulants. Prog Hemost Thromb 1982; 6: 263-286
